New drugs for early Alzheimer’s disease may allow people to live without help for up to 39 additional months, a new study estimates. But experts urge caution.

Navigating the challenges of an early-onset Alzheimer's diagnosis? This guide covers financial and legal considerations.

In the past two years, the Food and Drug Administration has approved two novel Alzheimer's therapies, based on data from ...

Doctors and aging experts say early intervention is key. When dementia is diagnosed early on, there are more treatment and ...

In the past two years, the Food and Drug Administration has approved two novel Alzheimer's therapies, based on data from clinical trials showing that both drugs slowed the progression of the disease.

Today, as part of a national initiative funded by The John A. Hartford Foundation (JAHF), the national, independent nonprofit FAIR Health launched a new shared decision-making tool for Alzheimer's ...

Nothing arouses the ire of nursing home consumer advocates like the term antipsychotics. A class of medications that was ...

Fraud, Arrogance, and Tragedy in the Quest to Cure Alzheimer’s,” Charles Piller looks how the amyloid hypothesis took over ...

In a heartwarming display of community spirit, Peter Bentley, the dedicated maintenance man at Coverage Care’s Greenfields ...

Joanna Paladino, MD, and colleagues identified four themes that may improve the delivery of a dementia diagnosis for clinicians, patients, and caregivers.

There is little, if any, difference in dementia patient behavioral care delivered through a health system than through a community-based organization or what has been standard care from a caregiver, ...